Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$364K Buy
1,164
+298
+34% +$87.5K 0.02% 136
2024
Q1
$246K Sell
866
-17
-2% -$4.97K 0.01% 157
2023
Q4
$254K Buy
+883
New +$241K 0.02% 160
2023
Q2
Sell
-873
Closed -$211K 173
2023
Q1
$211K Buy
873
+97
+13% +$23.8K 0.01% 152
2022
Q4
$204K Buy
+776
New +$208K 0.01% 170
2022
Q3
Sell
-878
Closed -$214K 179
2022
Q2
$214K Sell
878
-20
-2% -$4.9K 0.01% 143
2022
Q1
$217K Sell
898
-66
-7% -$15.2K 0.01% 163
2021
Q4
$217K Buy
+964
New +$203K 0.01% 170

Other funds holding AMGN

Arvest Trust's AMGN Position: Q2 2024 in Review

Arvest Trust increased its Amgen (AMGN) stake by 34% in Q2 2024, buying an estimated $87.5K and bringing the position to 1,164 shares worth $364K. The position accounts for 0.02% of the portfolio, ranked #136.

Arvest Trust first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Arvest Trust held 1,164 shares of Amgen worth $364K as of Q2 2024.
  • Arvest Trust bought 298 Amgen shares in Q2 2024, an estimated $87.5K.
  • Amgen made up 0.02% of Arvest Trust's portfolio in Q2 2024, its #136 holding.
  • Arvest Trust first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.